Financials
- Market Capitalization 8.04 B
- Employee 691
- Founded 2014
- CEO Rich Adcock
- Website www.immunitybio.com
- Headquarter Delaware, United States
- FIGI BBG007T9DYW9
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-9.02
市销率
51.72
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1030 | PCVX Vaxcyte, Inc. - Common Stock | 56.38 USD | +0.30% | -2.66% | +13.74% | +33.29% | 8.14 B USD | ||
| 1032 | IMVT Immunovant, Inc. - Common Stock | 39.44 USD | +1.73% | -1.42% | +18.76% | +105.31% | 8.10 B USD | ||
| 1057 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.94 USD | -0.06% | -3.92% | +18.66% | +56.24% | 7.74 B USD | ||
| 1077 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 109.56 USD | -0.36% | -2.47% | +20.48% | -0.68% | 7.51 B USD |